Facilitating Innovative Nuclear Diagnostics Act of 2023

Hozzl · 2023-12-13T08:30:22Z

Explore the details of House Bill 1199 Facilitating Innovative Nuclear Diagnostics Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/13/2023, 8:30 AM

Summary of Bill HR 1199

Bill 118 hr 1199, also known as the Facilitating Innovative Nuclear Diagnostics Act of 2023, aims to promote the development and use of innovative nuclear diagnostic technologies in the United States. The bill recognizes the importance of nuclear diagnostics in advancing medical research and improving patient care.

The key provisions of the bill include establishing a grant program to support research and development of new nuclear diagnostic technologies, as well as providing funding for training programs to educate healthcare professionals on the use of these technologies. The bill also calls for the establishment of a national registry to track the use and outcomes of nuclear diagnostic procedures.

Additionally, the bill seeks to streamline the regulatory approval process for new nuclear diagnostic technologies, in order to expedite their availability to patients. This includes provisions for the FDA to collaborate with industry stakeholders to develop guidelines for the approval of these technologies. Overall, the Facilitating Innovative Nuclear Diagnostics Act of 2023 aims to foster innovation in the field of nuclear diagnostics, improve patient outcomes, and advance medical research in the United States.

Congressional Summary of HR 1199

Facilitating Innovative Nuclear Diagnostics Act of 2023

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1199

Bill HR 1199 is currently in the status of Bill Introduced since February 27, 2023. Bill HR 1199 was introduced during Congress 118 and was introduced to the House on February 27, 2023. Bill HR 1199's most recent activity was Referred to the Subcommittee on Health. as of March 10, 2023

Bipartisan Support of Bill HR 1199

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1199

Primary Policy Focus

Health

Potential Impact Areas

- Health care costs and insurance

- Medical tests and diagnostic methods

- Medicare

- Radiation

Alternate Title(s) of Bill HR 1199

Facilitating Innovative Nuclear Diagnostics Act of 2023

To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, diagnostic radiopharmaceuticals under the Medicare hospital outpatient prospective payment system.